June 1-5th,2007 / Chicago, USA
Relevance of a medicosurgical strategy combining cetuximab and chronomodulated chemotherapy with metastases resection as 3rd line treatment for patients with metastatic colorectal cancer. Karaboue A., Bouchahda M., Adam A., Innominato I., Bralet M.P., Moreau T., Hauteville D., Guettier C., Levi F. J Clin Oncol 2007: 25 (18), suppl 14505.
